Showing results (241-250 of 413) with videos related to

Sort By:
Pageof 42
CA: a Cancer Journal for Clinicians|March 5, 2010
American Cancer Society guideline for the early detection of prostate cancer: update 2010Andrew M D Wolf, Richard C Wender, Ruth B Etzioni, et al.
The Lancet. Oncology|May 9, 2014
Addressing overdiagnosis and overtreatment in cancer: a prescription for changeLaura J Esserman, Ian M Thompson, Brian Reid, et al.
The Prostate|April 21, 2015
Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention TrialChristopher M Heaphy, Gaurav Gaonkar, Sarah B Peskoe, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 31, 2016
Metformin for Reducing Racial/Ethnic Difference in Prostate Cancer Incidence for Men with Type II DiabetesChen-Pin Wang, Donna M Lehman, Yui-Wing F Lam, et al.
Psychopharmacology|May 30, 2019
Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancerAlexandra M Sharp, Suphada Lertphinyowong, Samantha S Yee, et al.
BJU International|January 20, 2011
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancerSteven B Zeliadt, David F Penson, Carol M Moinpour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White menKathleen C Torkko, Adrie van Bokhoven, Phoung Mai, et al.
Cancer Causes & Control : CCC|November 22, 2015
Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention TrialJeannette M Schenk, Cathee Till, Ann W Hsing, et al.
Oncotarget|October 27, 2016
TGF-β signal rewiring sustains epithelial-mesenchymal transition of circulating tumor cells in prostate cancer xenograft hostsGuangcun Huang, Pawel A Osmulski, Hakim Bouamar, et al.
The Journal of Urology|February 13, 2014
Statin drug use is not associated with prostate cancer risk in men who are regularly screenedElizabeth A Platz, Catherine M Tangen, Phyllis J Goodman, et al.
Pageof 42